Tech Company Financing Transactions
Cyted Health Funding Round
Cyted Health, based in Cambridge, secured $44 million in funding from EQT Life Sciences and private investors.
Transaction Overview
Company Name
Announced On
9/2/2025
Transaction Type
Venture Equity
Amount
$44,000,000
Round
Series B
Investors
EQT Life Sciences (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate the commercial expansion of Cyted's diagnostics platform in the US, consolidate existing commercial success across the UK, and expand its portfolio of advanced diagnostic tests.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Undisclosed
Cambridge, Undisclosed
UK
Cambridge, Undisclosed
UK
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Our mission is to save lives through early disease detection using our non-endoscopic diagnostic technology. Cyted is a gastrointestinal health company that has created a non-endoscopic diagnostic platform to detect disease early and save lives. Our technologies are transforming access to digestive health for everyone, everywhere.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Marcel Gehrung
Browse more venture capital transactions:
Prev: 9/2/2025: Benefit Street Partners venture capital transaction
Next: 9/2/2025: Justyol venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs